Pub Date : 2026-01-29DOI: 10.1016/j.explore.2026.103339
Salvador Quiroz-González, Erika Elizabeth Rodríguez-Torres
Scientific understanding of acupuncture has advanced rapidly, yet its therapeutic effectiveness remains only partially explained by linear or reductionist models centered on neural or biochemical pathways. This article offers a theoretical reflection and conceptual proposal framing acupuncture as a complex adaptive system, in which healing emerges from dynamic interactions among practitioner, patient, and context. Drawing on systems theory and complexity science, the therapeutic process is conceptualized through an Input-Process-Output-Feedback (IPOF) model that captures biological, psychological, and relational dimensions of regulation. Within this framework, effectiveness is understood as an emergent property arising from recursive feedback loops that integrate sensory, cognitive, and emotional signals into systemic coherence. Acupuncture's outcomes thus transcend isolated mechanisms, reflecting the co-regulation of two living systems that evolve together across treatment sessions. This perspective encourages a shift from reductionist causality toward emergent functionality, in which effectiveness results from configuration rather than isolation. By reframing acupuncture within a systems-based paradigm, this reflection invites a more integrative understanding of therapeutic emergence, bridging experimental mechanisms with real-world effectiveness and fostering a science of dynamic healing.
{"title":"Acupuncture as a complex adaptive system: A theoretical reflection on therapeutic effectiveness and emergent healing.","authors":"Salvador Quiroz-González, Erika Elizabeth Rodríguez-Torres","doi":"10.1016/j.explore.2026.103339","DOIUrl":"https://doi.org/10.1016/j.explore.2026.103339","url":null,"abstract":"<p><p>Scientific understanding of acupuncture has advanced rapidly, yet its therapeutic effectiveness remains only partially explained by linear or reductionist models centered on neural or biochemical pathways. This article offers a theoretical reflection and conceptual proposal framing acupuncture as a complex adaptive system, in which healing emerges from dynamic interactions among practitioner, patient, and context. Drawing on systems theory and complexity science, the therapeutic process is conceptualized through an Input-Process-Output-Feedback (IPOF) model that captures biological, psychological, and relational dimensions of regulation. Within this framework, effectiveness is understood as an emergent property arising from recursive feedback loops that integrate sensory, cognitive, and emotional signals into systemic coherence. Acupuncture's outcomes thus transcend isolated mechanisms, reflecting the co-regulation of two living systems that evolve together across treatment sessions. This perspective encourages a shift from reductionist causality toward emergent functionality, in which effectiveness results from configuration rather than isolation. By reframing acupuncture within a systems-based paradigm, this reflection invites a more integrative understanding of therapeutic emergence, bridging experimental mechanisms with real-world effectiveness and fostering a science of dynamic healing.</p>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"22 2","pages":"103339"},"PeriodicalIF":2.2,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146127182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-28DOI: 10.1016/j.explore.2026.103338
Fei-Yi Zhao, Yan-Mei Wang, Qiang-Qiang Fu, Jia-Yi Zhu, Jie Qian
{"title":"From observed improvement to causal inference: Methodological challenges in a self-acupressure trial for multiple sclerosis.","authors":"Fei-Yi Zhao, Yan-Mei Wang, Qiang-Qiang Fu, Jia-Yi Zhu, Jie Qian","doi":"10.1016/j.explore.2026.103338","DOIUrl":"https://doi.org/10.1016/j.explore.2026.103338","url":null,"abstract":"","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"22 2","pages":"103338"},"PeriodicalIF":2.2,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146108252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-22DOI: 10.1016/j.explore.2026.103322
Wei Wang , Xiaofei Xie , Shengtao Cui , Lin Xue
{"title":"Corrigendum to “Clinical Efficacy of Guishao Shengxue Decoction in the Treatment of Pediatric Immune Thrombocytopenia: A Randomized Controlled Trial” [EXPLORE 21 (2025) 103277]","authors":"Wei Wang , Xiaofei Xie , Shengtao Cui , Lin Xue","doi":"10.1016/j.explore.2026.103322","DOIUrl":"10.1016/j.explore.2026.103322","url":null,"abstract":"","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"22 2","pages":"Article 103322"},"PeriodicalIF":2.2,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146038762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-21DOI: 10.1016/j.explore.2026.103327
Jiho Pyun , Manki Hwang , Taekyu Yang , Sungeun Kwon , Yoonchul Jung , Changsub Yeum , Seung-Hun Cho
Introduction
We evaluated the efficacy and safety of Taohong Siwu decoction (THSWD) as an adjunct to the usual therapy after surgery for tibiofibular fractures.
Methods
We conducted a comprehensive literature search across seven databases (MEDLINE [via PubMed], Embase, CENTRAL, CNKI, Wanfang, Sinomed, and CiNii) for relevant articles published from database inception through July 9, 2025. Meta-analyses were performed using a random-effects model. Depending on the outcome types, the results are reported as risk ratios (RRs), odds ratios (ORs), or mean differences (MDs), each with their corresponding 95% confidence intervals (CIs).
Results
We included 24 randomized controlled trials involving 2,048 participants. Compared to treatment as usual (TAU) alone, combined THSWD and TAU was associated with improvements in pain (MD -1.34; 95% CI -1.79 to -0.88, I² = 97%), time to fracture healing (MD -3.68; 95% CI -5.37 to -1.99, I² = 95%), the Hospital for Special Surgery Knee-Rating Scale score (MD 9.00; 95% CI 5.61 to 12.40), and the clinical response (RR = 1.16; 95% CI 1.12 to 1.21). The OR for adverse events was also significantly lower (OR 0.13; 95% CI 0.07 to 0.26) with THSWD combined with TAU. However, the included trials generally had low methodological quality, as assessed by RoB 2.0.
Conclusion
THSWD may serve as an effective adjunctive therapy to TAU to enhance recovery after tibiofibular fracture surgery, although the certainty of the evidence remains low, while potentially reducing adverse events.
Systematic Review Registration
www.crd.york.ac.uk/prospero (CRD420251107355)
前言:我们评价桃红四物汤作为胫腓骨骨折术后常规治疗的辅助治疗的有效性和安全性。方法我们对7个数据库(MEDLINE [via PubMed]、Embase、CENTRAL、CNKI、Wanfang、Sinomed和CiNii)进行了全面的文献检索,检索从数据库建立到2025年7月9日发表的相关文章。采用随机效应模型进行meta分析。根据结果类型,以风险比(rr)、优势比(ORs)或平均差异(MDs)报告结果,每个结果都有相应的95%置信区间(ci)。结果纳入24项随机对照试验,涉及2048名受试者。与单独常规治疗(TAU)相比,THSWD和TAU联合治疗与疼痛(MD -1.34; 95% CI -1.79至-0.88,I²= 97%)、骨折愈合时间(MD -3.68; 95% CI -5.37至-1.99,I²= 95%)、特殊外科医院膝关节评定量表评分(MD 9.00; 95% CI 5.61至12.40)和临床反应(RR = 1.16; 95% CI 1.12至1.21)的改善相关。THSWD联合TAU的不良事件OR也显著降低(OR 0.13; 95% CI 0.07 ~ 0.26)。然而,纳入的试验通常具有较低的方法学质量,如RoB 2.0评估。结论thswd可作为一种有效的辅助治疗来增强胫腓骨骨折手术后的恢复,尽管证据的确定性仍然很低,同时可能减少不良事件。系统评价注册www.crd.york.ac.uk/prospero (CRD420251107355)
{"title":"Herbal decoction with post-surgery for tibiofibular fracture: A systematic review","authors":"Jiho Pyun , Manki Hwang , Taekyu Yang , Sungeun Kwon , Yoonchul Jung , Changsub Yeum , Seung-Hun Cho","doi":"10.1016/j.explore.2026.103327","DOIUrl":"10.1016/j.explore.2026.103327","url":null,"abstract":"<div><h3>Introduction</h3><div>We evaluated the efficacy and safety of Taohong Siwu decoction (THSWD) as an adjunct to the usual therapy after surgery for tibiofibular fractures.</div></div><div><h3>Methods</h3><div>We conducted a comprehensive literature search across seven databases (MEDLINE [via PubMed], Embase, CENTRAL, CNKI, Wanfang, Sinomed, and CiNii) for relevant articles published from database inception through July 9, 2025. Meta-analyses were performed using a random-effects model. Depending on the outcome types, the results are reported as risk ratios (RRs), odds ratios (ORs), or mean differences (MDs), each with their corresponding 95% confidence intervals (CIs).</div></div><div><h3>Results</h3><div>We included 24 randomized controlled trials involving 2,048 participants. Compared to treatment as usual (TAU) alone, combined THSWD and TAU was associated with improvements in pain (MD -1.34; 95% CI -1.79 to -0.88, I² = 97%), time to fracture healing (MD -3.68; 95% CI -5.37 to -1.99, I² = 95%), the Hospital for Special Surgery Knee-Rating Scale score (MD 9.00; 95% CI 5.61 to 12.40), and the clinical response (RR = 1.16; 95% CI 1.12 to 1.21). The OR for adverse events was also significantly lower (OR 0.13; 95% CI 0.07 to 0.26) with THSWD combined with TAU. However, the included trials generally had low methodological quality, as assessed by RoB 2.0.</div></div><div><h3>Conclusion</h3><div>THSWD may serve as an effective adjunctive therapy to TAU to enhance recovery after tibiofibular fracture surgery, although the certainty of the evidence remains low, while potentially reducing adverse events.</div></div><div><h3>Systematic Review Registration</h3><div><span><span>www.crd.york.ac.uk/prospero</span><svg><path></path></svg></span> (CRD420251107355)</div></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"22 2","pages":"Article 103327"},"PeriodicalIF":2.2,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146078338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-20DOI: 10.1016/j.explore.2026.103326
Çiğdem Ergin , Songül Karadağ
Aim
This study aimed to evaluate the effects of acupressure on dyspnea and anxiety levels in patients with chronic obstructive pulmonary disease (COPD).
Design and Methods
A randomized controlled trial was conducted with 60 patients diagnosed with COPD. Acupressure was applied to the LI4, HT7, LU1, and ST36 points in the intervention group. Data were collected using the Modified Borg Scale (MBS), Medical Research Council Dyspnea Scale (MRC), and Beck Anxiety Inventory (BAI). A p-value of <0.05 was considered statistically significant.
Findings
Acupressure significantly reduced both dyspnoea and anxiety in the intervention group (p < 0.001). A moderate positive correlation was observed between dyspnea and anxiety scores.
Practice Implications
Acupressure may serve as a nurse-led, non-pharmacological intervention to manage symptoms in patients with COPD. Further studies are recommended to examine its broader clinical utility.
Relevance to Clinical Practice
Acupressure has the potential to enhance patient comfort and contribute to holistic symptom management in patients with COPD.
Patient or Public Contribution
While patients did not participate in the study design, data analysis, or manuscript writing, they actively engaged in the intervention by voluntarily accepting acupressure and consistently applying it at home. Their adherence provided insight into the feasibility of acupressure in real-world settings.
{"title":"Effects of acupressure on dyspnea and anxiety in patients with chronic obstructive pulmonary disease: A randomized controlled trial","authors":"Çiğdem Ergin , Songül Karadağ","doi":"10.1016/j.explore.2026.103326","DOIUrl":"10.1016/j.explore.2026.103326","url":null,"abstract":"<div><h3>Aim</h3><div>This study aimed to evaluate the effects of acupressure on dyspnea and anxiety levels in patients with chronic obstructive pulmonary disease (COPD).</div></div><div><h3>Design and Methods</h3><div>A randomized controlled trial was conducted with 60 patients diagnosed with COPD. Acupressure was applied to the LI4, HT7, LU1, and ST36 points in the intervention group. Data were collected using the Modified Borg Scale (MBS), Medical Research Council Dyspnea Scale (MRC), and Beck Anxiety Inventory (BAI). A p-value of <0.05 was considered statistically significant.</div></div><div><h3>Findings</h3><div>Acupressure significantly reduced both dyspnoea and anxiety in the intervention group (<em>p</em> < 0.001). A moderate positive correlation was observed between dyspnea and anxiety scores.</div></div><div><h3>Practice Implications</h3><div>Acupressure may serve as a nurse-led, non-pharmacological intervention to manage symptoms in patients with COPD. Further studies are recommended to examine its broader clinical utility.</div></div><div><h3>Relevance to Clinical Practice</h3><div>Acupressure has the potential to enhance patient comfort and contribute to holistic symptom management in patients with COPD.</div></div><div><h3>Patient or Public Contribution</h3><div>While patients did not participate in the study design, data analysis, or manuscript writing, they actively engaged in the intervention by voluntarily accepting acupressure and consistently applying it at home. Their adherence provided insight into the feasibility of acupressure in real-world settings.</div></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"22 2","pages":"Article 103326"},"PeriodicalIF":2.2,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146078444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-20DOI: 10.1016/j.explore.2026.103325
Geng-He Chang , Pey-Jium Chang , Yu-Ching Cheng , Ching-Yuan Wu , Yao-Hsu Yang , Yu-Shih Lin , Cheng-Ming Hsu , Ming-Shao Tsai , Yao-Te Tsai , Pei-Rung Yang
Background
Licorice (Glycyrrhiza glabra) is recognized for its anti-inflammatory and immune-regulating properties. It has demonstrated potential in managing inflammation associated with various respiratory and inflammatory disorders. This study aimed to evaluate the effectiveness and safety of a licorice nasal spray (LNS) compared to a conventional steroid nasal spray (SNS) in treating allergic rhinitis.
Methods
In a randomized clinical trial, 60 patients with allergic rhinitis were assigned to either LNS or SNS groups. The SNS group received mometasone furoate nasal spray (Nasonex®) administered as one spray per nostril twice daily (total daily dose 200 μg), while the LNS group received licorice nasal spray using the same dosing schedule. Both groups were treated twice daily for one month. Outcomes were assessed through symptom scores (TNSS, SNOT-22), Visual Analog Scale (VAS) for various symptoms, acoustic rhinometry, endoscopy, mucociliary transport time (MCTT), and cytokine levels in nasal secretions.
Results
Both LNS and SNS significantly reduced nasal blockage and postnasal drip. In addition, LNS was associated with improvements in rhinorrhea, itchy nose, and sleep quality. LNS was associated with significant reductions in IL-4, IL-6, IL-10, TNF-α, and IFN-γ in nasal secretions, whereas changes in SNS were observed in a more limited subset of cytokines. Additionally, LNS improved MCTT, indicating enhanced mucociliary function.
Conclusion
Licorice nasal spray effectively reduces allergic rhinitis symptoms and demonstrates a meaningful immunomodulatory effect comparable to steroid nasal spray. These results indicate that LNS may be a promising alternative therapy for patients with allergic rhinitis.
Trial registration
This study is prospectively registered with ISRCTN under the identifier ISRCTN13188211. Registration was completed on 01/09/2022, ensuring transparency and adherence to clinical trial reporting standards. Full trial details are accessible at https://www.isrctn.com/ISRCTN13188211.
{"title":"Efficacy and immunomodulatory effects of licorice nasal spray in allergic rhinitis: A clinical study comparing with conventional steroid treatment","authors":"Geng-He Chang , Pey-Jium Chang , Yu-Ching Cheng , Ching-Yuan Wu , Yao-Hsu Yang , Yu-Shih Lin , Cheng-Ming Hsu , Ming-Shao Tsai , Yao-Te Tsai , Pei-Rung Yang","doi":"10.1016/j.explore.2026.103325","DOIUrl":"10.1016/j.explore.2026.103325","url":null,"abstract":"<div><h3>Background</h3><div>Licorice (<em>Glycyrrhiza glabra</em>) is recognized for its anti-inflammatory and immune-regulating properties. It has demonstrated potential in managing inflammation associated with various respiratory and inflammatory disorders. This study aimed to evaluate the effectiveness and safety of a licorice nasal spray (LNS) compared to a conventional steroid nasal spray (SNS) in treating allergic rhinitis.</div></div><div><h3>Methods</h3><div>In a randomized clinical trial, 60 patients with allergic rhinitis were assigned to either LNS or SNS groups. The SNS group received mometasone furoate nasal spray (Nasonex®) administered as one spray per nostril twice daily (total daily dose 200 μg), while the LNS group received licorice nasal spray using the same dosing schedule. Both groups were treated twice daily for one month. Outcomes were assessed through symptom scores (TNSS, SNOT-22), Visual Analog Scale (VAS) for various symptoms, acoustic rhinometry, endoscopy, mucociliary transport time (MCTT), and cytokine levels in nasal secretions.</div></div><div><h3>Results</h3><div>Both LNS and SNS significantly reduced nasal blockage and postnasal drip. In addition, LNS was associated with improvements in rhinorrhea, itchy nose, and sleep quality. LNS was associated with significant reductions in IL-4, IL-6, IL-10, TNF-α, and IFN-γ in nasal secretions, whereas changes in SNS were observed in a more limited subset of cytokines. Additionally, LNS improved MCTT, indicating enhanced mucociliary function.</div></div><div><h3>Conclusion</h3><div>Licorice nasal spray effectively reduces allergic rhinitis symptoms and demonstrates a meaningful immunomodulatory effect comparable to steroid nasal spray. These results indicate that LNS may be a promising alternative therapy for patients with allergic rhinitis.</div></div><div><h3>Trial registration</h3><div>This study is prospectively registered with ISRCTN under the identifier ISRCTN13188211. Registration was completed on 01/09/2022, ensuring transparency and adherence to clinical trial reporting standards. Full trial details are accessible at <span><span>https://www.isrctn.com/ISRCTN13188211</span><svg><path></path></svg></span>.</div></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"22 2","pages":"Article 103325"},"PeriodicalIF":2.2,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146078184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cannulation-related pain is a common problem in hemodialysis patients with arteriovenous fistulas (AVFs). Identifying effective non-pharmacological strategies, such as Hegu (LI4) point acupressure, may help improve patient comfort. This study examined the effect of Hegu point acupressure on cannulation-related pain in hemodialysis patients with AVFs located in different anatomical regions.
Material and Methods
This randomized controlled study included 131 hemodialysis patients at a university dialysis center between October 2022 and February 2023. Patients had AVFs in antecubital, Brescia-Cimino, or snuff-box regions and were randomly assigned to intervention or control groups. The intervention consisted of three minutes of Hegu acupressure before cannulation, applied across three consecutive dialysis sessions. Pain intensity during needle insertion was assessed with the Numerical Rating Scale. Control patients received routine care. Data were analyzed using mixed-design ANOVA, and effect sizes were calculated with Cohen’s d.
Results
Pain scores in intervention groups decreased significantly across all fistula sites, with the most pronounced reduction in the Brescia-Cimino site (from 2.18 ± 0.95 to 0.81 ± 0.20). Decreases were also observed in the antecubital (from 2.14 ± 1.08 to 1.13 ± 0.46) and snuff-box sites (from 1.82 ± 0.13 to 1.09 ± 0.86). In contrast, pain scores in control groups remained stable or increased. Group and time interaction effects were significant across all sites (p < 0.05), with large effect sizes favoring acupressure.
Conclusion
Hegu point acupressure reduced cannulation pain in patients with AVFs at different anatomical sites, with the strongest effect in the Brescia-Cimino region.
{"title":"Hegu point acupressure for cannulation pain across fistula sites: Randomized controlled trial","authors":"Gülay TURGAY , Banu ÇEVİK , Yasemin ESKİGÜLEK , Işılay İNANOĞLU , Semiha KAYA","doi":"10.1016/j.explore.2026.103324","DOIUrl":"10.1016/j.explore.2026.103324","url":null,"abstract":"<div><h3>Background</h3><div>Cannulation-related pain is a common problem in hemodialysis patients with arteriovenous fistulas (AVFs). Identifying effective non-pharmacological strategies, such as Hegu (LI4) point acupressure, may help improve patient comfort. This study examined the effect of Hegu point acupressure on cannulation-related pain in hemodialysis patients with AVFs located in different anatomical regions.</div></div><div><h3>Material and Methods</h3><div>This randomized controlled study included 131 hemodialysis patients at a university dialysis center between October 2022 and February 2023. Patients had AVFs in antecubital, Brescia-Cimino, or snuff-box regions and were randomly assigned to intervention or control groups. The intervention consisted of three minutes of Hegu acupressure before cannulation, applied across three consecutive dialysis sessions. Pain intensity during needle insertion was assessed with the Numerical Rating Scale. Control patients received routine care. Data were analyzed using mixed-design ANOVA, and effect sizes were calculated with Cohen’s d.</div></div><div><h3>Results</h3><div>Pain scores in intervention groups decreased significantly across all fistula sites, with the most pronounced reduction in the Brescia-Cimino site (from 2.18 ± 0.95 to 0.81 ± 0.20). Decreases were also observed in the antecubital (from 2.14 ± 1.08 to 1.13 ± 0.46) and snuff-box sites (from 1.82 ± 0.13 to 1.09 ± 0.86). In contrast, pain scores in control groups remained stable or increased. Group and time interaction effects were significant across all sites (<em>p</em> < 0.05), with large effect sizes favoring acupressure.</div></div><div><h3>Conclusion</h3><div>Hegu point acupressure reduced cannulation pain in patients with AVFs at different anatomical sites, with the strongest effect in the Brescia-Cimino region.</div></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"22 2","pages":"Article 103324"},"PeriodicalIF":2.2,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146030318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-14DOI: 10.1016/j.explore.2026.103316
Mary Jo Kreitzer, Mary Koithan
{"title":"Integrative nursing: A whole health perspective.","authors":"Mary Jo Kreitzer, Mary Koithan","doi":"10.1016/j.explore.2026.103316","DOIUrl":"https://doi.org/10.1016/j.explore.2026.103316","url":null,"abstract":"","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"22 2","pages":"103316"},"PeriodicalIF":2.2,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146127288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-14DOI: 10.1016/j.explore.2026.103323
Chun Yiu Lam , Lap Kwan Leung Cyrus , Kin Kit Li Ben
The Sound Magnetic Balance Intervention (SMBI) is a novel integrated therapy that combines sound healing using Tibetan singing bowls, tuning forks, with magnetic meridian massage based on principles of Traditional Chinese Medicine (TCM). This randomized controlled trial (RCT) was the first to evaluate the combined effects of these modalities on psychological, physiological, and somatic outcomes. Forty-six university students (mean age = 20.65, SD = 2.24) with mild psychological distress were randomly assigned to receive SMBI as the intervention condition or one of two active controls, either calming music or an audio story. Compared to both control groups, SMBI significantly reduced depression, anxiety, and stress (p < .001, η² = 0.31–0.55), stagnation (p < .001, η² = 0.37), acupoint pain (p < .001, η² = 0.63–0.82), heart rate, and systolic blood pressure (p < .001, η² = 0.50–0.58), and also improved life satisfaction and spiritual well-being (p < .001, η² = 0.14–0.37). Delivered in three 30–35 min sessions and requiring only 10–15 h of practitioner training, SMBI is a non-invasive, cost-effective intervention with potential for use in clinical and community settings. Future research should investigate physiological and neurobiological mechanisms (e.g., cortisol, EEG) and examine integration with other TCM modalities. These findings position SMBI as a promising multisensory approach within the field of integrative mental health care.
{"title":"Evaluating the sound magnetic balance intervention in a randomized controlled trial: Effects on psychological distress, somatic pain, and physiological arousal","authors":"Chun Yiu Lam , Lap Kwan Leung Cyrus , Kin Kit Li Ben","doi":"10.1016/j.explore.2026.103323","DOIUrl":"10.1016/j.explore.2026.103323","url":null,"abstract":"<div><div>The Sound Magnetic Balance Intervention (SMBI) is a novel integrated therapy that combines sound healing using Tibetan singing bowls, tuning forks, with magnetic meridian massage based on principles of Traditional Chinese Medicine (TCM). This randomized controlled trial (RCT) was the first to evaluate the combined effects of these modalities on psychological, physiological, and somatic outcomes. Forty-six university students (mean age = 20.65, SD = 2.24) with mild psychological distress were randomly assigned to receive SMBI as the intervention condition or one of two active controls, either calming music or an audio story. Compared to both control groups, SMBI significantly reduced depression, anxiety, and stress (<em>p</em> < .001, η² = 0.31–0.55), stagnation (<em>p</em> < .001, η² = 0.37), acupoint pain (<em>p</em> < .001, η² = 0.63–0.82), heart rate, and systolic blood pressure (<em>p</em> < .001, η² = 0.50–0.58), and also improved life satisfaction and spiritual well-being (<em>p</em> < .001, η² = 0.14–0.37). Delivered in three 30–35 min sessions and requiring only 10–15 h of practitioner training, SMBI is a non-invasive, cost-effective intervention with potential for use in clinical and community settings. Future research should investigate physiological and neurobiological mechanisms (e.g., cortisol, EEG) and examine integration with other TCM modalities. These findings position SMBI as a promising multisensory approach within the field of integrative mental health care.</div></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"22 2","pages":"Article 103323"},"PeriodicalIF":2.2,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146078336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-13DOI: 10.1016/j.explore.2026.103321
Hai Tang , Mengyu Liu , Zijian Zhou , Hui Liu , Zhijie Ji , Min Yang , Jinfeng Shen , Maoyin Zhang
Background
This study evaluated the effect of inhaled peppermint essential oil (PEO) aromatherapy on postoperative nausea and vomiting (PONV) in patients undergoing laparoscopic gynecologic surgery.
Methods
In this randomized controlled trial, 106 patients were assigned to either the PEO group or normal saline (NS) group. The PEO group received inhalational aromatherapy with 2% peppermint oil before induction, preoperatively, and immediately after extubation. The NS group received an identical intervention using 2 ml of 0.9% sodium chloride solution.
Results
Compared with the NS group, the PEO group had a significantly lower incidence of PONV within 24 h (52.8% vs. 73.6%; p = 0.043). The reduction was most notable during the first hour (45.3% vs. 73.6%; p = 0.047). The PEO group also demonstrated significantly improved anxiety scores at 0–24 h and 24–48 h, reduced pain catastrophizing, and decreased abdominal distension.
Conclusion
Inhaled peppermint aromatherapy reduced the incidence of PONV, improved anxiety, decreased pain catastrophizing, and alleviated abdominal distension in patients undergoing laparoscopic gynecological surgery.
Clinical Trial Registration
This study was registered in the Chinese Clinical Trial Registry. (Registration number: ChiCTR2400093289 Registration Date:2024–12–02)
本研究评估了吸入薄荷精油(PEO)芳香疗法对腹腔镜妇科手术患者术后恶心呕吐(PONV)的影响。方法将106例患者随机分为生理盐水组和PEO组。PEO组在诱导前、术前和拔管后立即接受2%薄荷油的吸入芳香疗法。NS组接受相同的干预,使用2ml 0.9%氯化钠溶液。结果与NS组相比,PEO组24 h内PONV发生率显著降低(52.8% vs. 73.6%; p = 0.043)。在第1小时减少最为显著(45.3% vs. 73.6%; p = 0.047)。PEO组在0-24 h和24-48 h的焦虑评分也有显著改善,疼痛灾难性减轻,腹胀减轻。结论吸入性薄荷香薰治疗可降低腹腔镜妇科手术患者PONV的发生率,改善患者的焦虑感,减轻疼痛的发生,减轻腹胀。临床试验注册本研究已在中国临床试验注册中心注册。(注册号:ChiCTR2400093289注册日期:2024-12-02)
{"title":"Effect of inhaled peppermint essential oil aromatherapy on postoperative nausea and vomiting in patients undergoing laparoscopic gynecologic surgery","authors":"Hai Tang , Mengyu Liu , Zijian Zhou , Hui Liu , Zhijie Ji , Min Yang , Jinfeng Shen , Maoyin Zhang","doi":"10.1016/j.explore.2026.103321","DOIUrl":"10.1016/j.explore.2026.103321","url":null,"abstract":"<div><h3>Background</h3><div>This study evaluated the effect of inhaled peppermint essential oil (PEO) aromatherapy on postoperative nausea and vomiting (PONV) in patients undergoing laparoscopic gynecologic surgery.</div></div><div><h3>Methods</h3><div>In this randomized controlled trial, 106 patients were assigned to either the PEO group or normal saline (NS) group. The PEO group received inhalational aromatherapy with 2% peppermint oil before induction, preoperatively, and immediately after extubation. The NS group received an identical intervention using 2 ml of 0.9% sodium chloride solution.</div></div><div><h3>Results</h3><div>Compared with the NS group, the PEO group had a significantly lower incidence of PONV within 24 h (52.8% vs. 73.6%; <em>p</em> = 0.043). The reduction was most notable during the first hour (45.3% vs. 73.6%; <em>p</em> = 0.047). The PEO group also demonstrated significantly improved anxiety scores at 0–24 h and 24–48 h, reduced pain catastrophizing, and decreased abdominal distension.</div></div><div><h3>Conclusion</h3><div>Inhaled peppermint aromatherapy reduced the incidence of PONV, improved anxiety, decreased pain catastrophizing, and alleviated abdominal distension in patients undergoing laparoscopic gynecological surgery.</div></div><div><h3>Clinical Trial Registration</h3><div>This study was registered in the Chinese Clinical Trial Registry. (Registration number: ChiCTR2400093289 Registration Date:2024–12–02)</div></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"22 2","pages":"Article 103321"},"PeriodicalIF":2.2,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145979382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}